No image
Alere NMP22 Test
For the in vitro quantitative measurement of the Nuclear Matrix Protein NMP22 in stabilized urine (ELISA).
Details
Device typeNuclear matrix protein 22 IVD, kit, enzyme immunoassay (EIA): A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of nuclear matrix protein 22 (NMP22) [also known as nuclear mitotic apparatus protein 1] in a clinical specimen, using an enzyme immunoassay (EIA) method. It is typically used to aid in the diagnosis of urological conditions (e.g., bladder cancer, prostate cancer).
FDA categorySystem, Test, Tumor Marker, For Detection Of Bladder Cancer
Device ID10811877010545
Single useYes
MRI safetyLabeling does not contain MRI Safety Information